30 July 2020 — GE Healthcare and Osprey Medical Inc.
(ASX:OSP) (Osprey) today announced a strategic alliance under which GE Healthcare will exclusively distribute Osprey’s
product portfolio in Europe, Russia, Middle East, Africa, Central Asia and Turkey.
Under the four-year agreement, GE Healthcare will commercialize Osprey’s DyeVert portfolio which reduces the
amount of contrast that reaches the kidney (40% average reduction) with no compromise in image quality.
The announcement doesn't appear to show any projections or forecasts